Comparing two pain management techniques for patients undergoing heart valve replacement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of two different analgesic techniques, the Pericapsular Nerve Group Block (PENG) and the Fascia Iliaca Block (FIB), in managing postoperative pain for patients undergoing Transcatheter Aortic Valve Implantation (TAVI). The study aims to determine which method provides better pain relief without motor block, thereby improving recovery outcomes for patients with aortic stenosis. Participants will be selected based on specific criteria, including age and physical health status, and will be monitored for pain management effectiveness post-procedure.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients scheduled for TAVİ
* aged between 18 and 85 years,
* American Society of Anesthesiology (ASA) physical status II-IV

Exclusion Criteria:

* History of bleeding diathesis.
* Use of anticoagulant therapy.
* History of chronic pain prior to surgery.
* Multiple trauma.
* Conditions where pain assessment cannot be performed (e.g., dementia).
* Patients operated under spinal or epidural anesthesia.
* Presence of infection in the region where the block will be applied.
* Refusal to consent to the procedure

Where it's running

• Medipol University
  Istanbul, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Burak Ömür
• Email: bomur@medipol.edu.tr
• Phone: +905056215056

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Remote monitoring for patients after heart valve replacement

  This study tests if using remote monitoring can help patients who have had heart valve replacement recover better and go home sooner by catching any problems early.

  Recruiting Imperial College London · London · NCT06602609

• Transcatheter Aortic Valve Replacement Registry for Outcomes and Quality Monitoring

  This registry collects information from hospitals about patients undergoing TAVR to see how care and outcomes compare to guidelines and nationwide data.

  Recruiting American College of Cardiology · Washington D.C., District of Columbia · NCT07908355

• Vericiguat to slow calcific aortic valve narrowing

  This trial tests whether vericiguat can slow the progression of mild-to-moderate calcific aortic valve stenosis compared with placebo.

  Recruiting Phase 2 West China Hospital · Chengdu, Sichuan · NCT07715279

• CHATEAU Registry: Real-world outcomes after TAVR

  This registry collects real-world data from adults who had TAVR between 2021 and 2025 to see how they do over time and how valve performance holds up.

  Recruiting Eunpyeong St. Mary's Hospital · Seoul · NCT07709858

• Impact of TAVR on kidney function in people with aortic valve disease

  This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, RM · NCT07626710

• Analgesia after total hip replacement using SA-QLB vs PENG block

  This study tests whether the SA-QLB or the PENG block provides better pain relief for adults having a total hip replacement.

  Recruiting Tanta University · Tanta, El-Gharbia · NCT07606794

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.